关于SUpira系统在接受高风险经皮冠状动脉介入治疗(HRPCI)患者中应用的关键性随机研究 (SUPPORT II)
SUpira系统在高危经皮冠状动脉介入治疗(HRPCI)患者中的关键性随机研究
The objective of this study is to assess the safety and efficacy of the Supira System in providing temporary cardiovascular hemodynamic support in patients undergoing HRPCI. Eligible patients will be randomized to undergo HRPCI with either the Supira System (investigational device) or the commercially available Impella systems (comparator device).
研究概览
详细说明
The Supira System is a minimally invasive percutaneous ventricular assist device (pVAD) that is intended to provide temporary hemodynamic support (≤ 4 hours) to patients undergoing HRPCI. The Supira Catheter is inserted percutaneously through the femoral artery, across the aortic valve, and into the left ventricle under fluoroscopic guidance, with the pump outlet remaining in the ascending aorta. The pump portion of the Catheter compresses during insertion in the Introducer Sheath and re-expands during use. It actively unloads the left ventricle by pumping blood from the ventricle into the ascending aorta and systemic circulation.
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名:Supira Medical
- 电话号码:(669) 330-0883
- 邮箱:clinical@supiramedical.com
研究联系人备份
- 姓名:Chris DeMorett
学习地点
-
-
California
-
Loma Linda、California、美国、92354
- 招聘中
- Loma Linda University Medical Center
-
首席研究员:
- VInoy Prasad, M.D.
-
接触:
- Vinoy Prasad, M.D.
- 电话号码:909-558-4200
- 邮箱:khefflin@llu.edu
-
Sacramento、California、美国、95817
- 招聘中
- UC Davis
-
接触:
- Garrett Wong, M.D.
-
首席研究员:
- Garrett Wong, M.D.
-
Thousand Oaks、California、美国、91360
- 招聘中
- Los Robles Regional Medical Center
-
首席研究员:
- Saibal Kar, M.D.
-
接触:
- Saibal Kar, M.D.
- 电话号码:805-852-9100
- 邮箱:mane.arabyan@hcahealthcare.com
-
-
Florida
-
Miami、Florida、美国、33136
- 招聘中
- University of Miami
-
接触:
- Barbara Lang
- 电话号码:305-243-4950
- 邮箱:blang@med.miami.edu
-
首席研究员:
- Aditya Bharadwaj, M.D.
-
-
Georgia
-
Atlanta、Georgia、美国、30322
- 招聘中
- Emory University Hospital
-
首席研究员:
- Bill Nicholson, M.D.
-
接触:
- Bill Nicholson, M.D.
- 邮箱:wei.xu@emory.edu
-
Atlanta、Georgia、美国、30309
- 招聘中
- Piedmont Heart Institute
-
接触:
- David Kandzari, M.D.
-
首席研究员:
- David Kandzari, M.D.
-
Lawrenceville、Georgia、美国、30046
- 招聘中
- Northside Hospital
-
接触:
- Troy Crain
- 电话号码:678-312-3828
- 邮箱:Troy.Crain@northside.com
-
首席研究员:
- Michele Voeltz, M.D.
-
-
Illinois
-
Chicago、Illinois、美国、60611
- 招聘中
- Northwestern University
-
接触:
- Joaquim Barboza, M.D.
- 电话号码:312-664-3278
- 邮箱:droshevs@nm.org
-
首席研究员:
- Joaquim Barboza, M.D.
-
-
Michigan
-
Detroit、Michigan、美国、48236
- 招聘中
- Henry Ford Health / St. John Hospital
-
接触:
- Amir Kaki, M.D.
-
首席研究员:
- Amir Kaki, M.D.
-
-
Minnesota
-
Saint Cloud、Minnesota、美国、56362
- 招聘中
- CentraCare
-
接触:
- Stephen Kidd, M.D.
-
首席研究员:
- Stephen Kidd, M.D.
-
-
Missouri
-
St Louis、Missouri、美国、63110
- 招聘中
- Washington University in St. Louis
-
首席研究员:
- John Lasala, M.D.
-
接触:
- John Lasala, M.D.
- 电话号码:314-362-1291
- 邮箱:cjenifer@wustl.edu
-
-
New Jersey
-
Camden、New Jersey、美国、08103
- 招聘中
- Virtua Health
-
接触:
- Kristin Wade
- 电话号码:856-355-1225
- 邮箱:KMWADE@virtua.org
-
首席研究员:
- Kintur Sanghvi, M.D>
-
Paramus、New Jersey、美国、07652
- 招聘中
- The Valley Hospital
-
接触:
- Kimberly Michel
- 电话号码:201-447-8453
- 邮箱:KMICHEL@Valleyhealth.com
-
首席研究员:
- Raj Tayal, M.D.
-
-
New York
-
Buffalo、New York、美国、14203
- 招聘中
- University of Buffalo (Buffalo General)
-
首席研究员:
- Vijay Iyer, M.D.
-
接触:
- Vijay Iyer, M.D.
- 电话号码:716-710-8266
- 邮箱:ehejna@buffalo.edu
-
New York、New York、美国、10032
- 招聘中
- Cuimc/Nyph
-
接触:
- Megha Prasad, M.D.
-
首席研究员:
- Megha Prasad, M.D.
-
副研究员:
- Ajay Kirtane, M.D.
-
The Bronx、New York、美国、10467
- 招聘中
- Montefiore Medical Center
-
接触:
- Andrea Mignatti, M.D.
-
首席研究员:
- Andrea Mignatti, M.D.
-
-
North Carolina
-
Asheville、North Carolina、美国、28803
- 招聘中
- Mission Health
-
接触:
- Josie Routhier
- 电话号码:828-274-6001
- 邮箱:Josephine.Routhier@HCAHealthcare.com
-
首席研究员:
- Michael Chenier, M.D.
-
-
Ohio
-
Columbus、Ohio、美国、43214
- 招聘中
- OhioHealth
-
首席研究员:
- Arash Arshi, M.D.
-
接触:
- Arash Arshi, M.D.
- 电话号码:614-262-6772
- 邮箱:joanna.flores-jones@ohiohealth.com
-
-
Oklahoma
-
Tulsa、Oklahoma、美国、74104
- 招聘中
- Oklahoma Heart Hillcrest Medical
-
首席研究员:
- Kamran Muhammad, M.D.
-
接触:
- Kamran Muhammad, M.D.
-
-
Oregon
-
Portland、Oregon、美国、97239
- 招聘中
- OHSU
-
接触:
- Firas Zahr, M.D.
- 电话号码:503-494-1775
- 邮箱:sampsonna@ohsu.edu
-
首席研究员:
- Firas Zahr, M.D.
-
Portland、Oregon、美国、97225
- 招聘中
- Providence
-
接触:
- Sheryl Ames
- 电话号码:503-216-2099
- 邮箱:Sheryl.Ames@providence.org
-
首席研究员:
- Kathryn Dawson, M.D.
-
-
Pennsylvania
-
Philadelphia、Pennsylvania、美国、19104
- 招聘中
- University of Pennsylvania
-
接触:
- Joyce Wald, D.O.
- 电话号码:215-615-4949
- 邮箱:alyson.brown@pennmedicine.upenn.edu
-
首席研究员:
- Joyce Wald, D.O.
-
首席研究员:
- Jay Giri, M.D.
-
York、Pennsylvania、美国、17403
- 招聘中
- Wellspan York Hospital
-
首席研究员:
- Rhian Davies, D.O.
-
接触:
- Rhian Davies, D.O.
- 电话号码:717-851-5153
- 邮箱:hmckinney@wellspan.org
-
-
South Carolina
-
Columbia、South Carolina、美国、29203
- 招聘中
- Prisma Health
-
首席研究员:
- Vince Vismara, M.D.
-
接触:
- Vince Vismara, M.D.
- 电话号码:803-434-3800
- 邮箱:Suzanne.Smith@PrismaHealth.org
-
-
Texas
-
Plano、Texas、美国、75093
- 招聘中
- Baylor Scott & White The Heart Hospital
-
首席研究员:
- Karim Al-Azizi, M.D.
-
接触:
- Karim Al-Azizi, M.D.
- 电话号码:469-800-6300
- 邮箱:Osniel.GonzalezRamos@BSWHealth.org
-
-
Utah
-
Murray、Utah、美国、84107
- 招聘中
- Intermountain Health
-
接触:
- Savanna Chhak
- 电话号码:801-507-4731
- 邮箱:Savanna.Chhak@imail.org
-
首席研究员:
- Mitul Patel, M.D.
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Hemodynamically stable and will undergo elective or urgent (not emergent) HRPCI, where hemodynamic support is deemed necessary, as determined by the institutional Heart Team
- Informed consent granted by the subject or legally authorized representative
Exclusion Criteria:
- Cardiogenic shock or acutely decompensated pre-existing chronic heart failure
- Stroke within 6 months of the index procedure, or any prior stroke with permanent neurologic deficit
- Left ventricular thrombus
- Aortic and iliofemoral anatomical conditions that preclude safe delivery and placement of the investigational device or the comparator device
- Ongoing renal replacement therapy with dialysis
- Presence of decompensated liver disease; severe liver dysfunction
- Infection of the proposed procedural access site or active infection
- Known hypersensitivity to intravenous contrast agents that cannot be adequately pre-medicated or known hypersensitivity to heparin, aspirin, adenosine diphosphate (ADP) receptor inhibitors, or nitinol
- Any condition, coagulopathy, planned procedure or contraindication that requires discontinuation of antiplatelet and/or anticoagulant therapy within 90 days of the index procedure
- Breastfeeding or pregnant or planning to become pregnant within 90 days of the HRPCI procedure
- Currently participating in active follow-up phase of another clinical study of an investigational drug or device or planning to enroll in such a study within 90 days of the HRPCI procedure
- Other medical, social, or psychological problems that, in the opinion of the Investigator, compromises the subject's ability to provide written informed consent and/or to comply with study procedures
- Considered to be part of a vulnerable population per the investigator's assessment
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Supira System
Subjects receiving the Supira System |
The Supira System is a temporary (≤ 4 hours) ventricular support device indicated for use during elective or urgent HRPCI performed in hemodynamically stable patients with severe coronary artery disease when a heart team has determined HRPCI is the appropriate therapeutic option. |
|
有源比较器:Impella
Subjects receiving the Impella |
The current commercially available Impella CP with SmartAssist Catheter is indicated for providing temporary (≤ 6 hours) ventricular support during elective or urgent high risk percutaneous coronary i |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Composite Safety and Efficacy Outcomes
大体时间:30 days
|
|
30 days
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Secondary Outcome Measures
大体时间:30 and 90 days
|
Individual rates of the following outcomes:
|
30 and 90 days
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.